Sichuan Kelun Pharmaceutical Co., Ltd.
SZSE:002422.SZ
26.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 21,151.203 | 18,912.653 | 17,277.408 | 16,464.201 | 17,636.267 | 16,351.79 | 11,434.949 | 8,565.943 | 7,763.34 | 8,023.421 | 6,831.282 | 5,885.279 | 5,147.849 | 4,026.4 | 3,245.985 | 2,621.391 | 2,029.327 |
| Cost of Revenue
| 10,449.421 | 8,959.199 | 7,660.152 | 7,532.912 | 7,022.557 | 6,612.152 | 5,567.765 | 4,854.666 | 4,505.536 | 4,607.807 | 3,712.055 | 3,374.229 | 2,944.997 | 2,373.501 | 1,991.066 | 1,673.006 | 1,297.557 |
| Gross Profit
| 10,701.782 | 9,953.454 | 9,617.255 | 8,931.289 | 10,613.71 | 9,739.638 | 5,867.184 | 3,711.278 | 3,257.804 | 3,415.615 | 3,119.226 | 2,511.05 | 2,202.852 | 1,652.898 | 1,254.919 | 948.385 | 731.77 |
| Gross Profit Ratio
| 0.506 | 0.526 | 0.557 | 0.542 | 0.602 | 0.596 | 0.513 | 0.433 | 0.42 | 0.426 | 0.457 | 0.427 | 0.428 | 0.411 | 0.387 | 0.362 | 0.361 |
| Reseach & Development Expenses
| 1,808.185 | 1,795.088 | 1,736.587 | 1,527.331 | 1,285.867 | 885.231 | 712.213 | 547.44 | 434.163 | 312.351 | 300.058 | 186.545 | 136.43 | 71.437 | 34.914 | 10.427 | 11.035 |
| General & Administrative Expenses
| 382.891 | 311.688 | 319.977 | 294.867 | 213.213 | 160.864 | 125.035 | 183.119 | 165.879 | 152.47 | 110.009 | 97.239 | 81.611 | 84.597 | 49.748 | 45.435 | 47.653 |
| Selling & Marketing Expenses
| 4,449.718 | 4,685.948 | 5,022.333 | 4,882.545 | 6,550.305 | 5,987.227 | 3,073.855 | 1,254.483 | 1,027.937 | 1,048.872 | 887.039 | 696.745 | 692.364 | 592.444 | 500.889 | 394.464 | 311.085 |
| SG&A
| 5,529.254 | 4,997.636 | 5,342.31 | 5,177.412 | 6,763.519 | 6,148.091 | 3,198.89 | 1,437.602 | 1,193.816 | 1,201.343 | 997.048 | 793.985 | 773.975 | 677.041 | 550.637 | 439.899 | 358.739 |
| Other Expenses
| -85.436 | 626.896 | 829.694 | 590.599 | 753.48 | -22.795 | -15.556 | 63.955 | 112.095 | 75.808 | 146.647 | 138.167 | 60.117 | 30.883 | 26.013 | 2.592 | 9.961 |
| Operating Expenses
| 7,422.875 | 7,419.62 | 7,908.591 | 7,295.342 | 8,802.865 | 7,773.989 | 4,617.011 | 2,625.34 | 2,164.554 | 1,975.713 | 1,648.866 | 1,274.745 | 1,128.553 | 886.824 | 698.677 | 544.797 | 446.661 |
| Operating Income
| 3,278.907 | 2,198.86 | 1,793.267 | 1,638.317 | 1,976.672 | 1,356.2 | 1,156.833 | 668.058 | 573.504 | 1,088.752 | 1,148.539 | 1,134.82 | 1,060.226 | 754.409 | 505.556 | 353.109 | 246.474 |
| Operating Income Ratio
| 0.155 | 0.116 | 0.104 | 0.1 | 0.112 | 0.083 | 0.101 | 0.078 | 0.074 | 0.136 | 0.168 | 0.193 | 0.206 | 0.187 | 0.156 | 0.135 | 0.121 |
| Total Other Income Expenses Net
| -50.587 | -127.396 | -615.651 | -683.287 | -720.378 | -632.244 | -108.897 | -369.512 | -412.433 | -291.194 | -187.852 | 32.219 | 43.742 | 9.022 | -34.326 | -52.074 | -28.956 |
| Income Before Tax
| 3,228.321 | 2,071.464 | 1,177.616 | 955.031 | 1,256.294 | 1,333.404 | 1,141.276 | 716.426 | 680.817 | 1,148.708 | 1,282.509 | 1,268.523 | 1,118.042 | 775.097 | 521.916 | 351.514 | 256.153 |
| Income Before Tax Ratio
| 0.153 | 0.11 | 0.068 | 0.058 | 0.071 | 0.082 | 0.1 | 0.084 | 0.088 | 0.143 | 0.188 | 0.216 | 0.217 | 0.193 | 0.161 | 0.134 | 0.126 |
| Income Tax Expense
| 933.787 | 364.002 | 309.499 | 163.554 | 234.753 | 65.92 | 330.194 | 92.101 | 138.927 | 164.026 | 191.01 | 174.87 | 157.05 | 113.41 | 87.745 | 40.549 | 40.667 |
| Net Income
| 2,456.112 | 1,705.324 | 868.117 | 829.386 | 937.855 | 1,212.944 | 748.544 | 584.639 | 645.271 | 1,001.903 | 1,079.522 | 1,087.516 | 966.126 | 661.229 | 427.851 | 309.887 | 216.288 |
| Net Income Ratio
| 0.116 | 0.09 | 0.05 | 0.05 | 0.053 | 0.074 | 0.065 | 0.068 | 0.083 | 0.125 | 0.158 | 0.185 | 0.188 | 0.164 | 0.132 | 0.118 | 0.107 |
| EPS
| 1.69 | 1.22 | 0.61 | 0.58 | 0.66 | 0.85 | 0.52 | 0.41 | 0.45 | 0.7 | 0.75 | 0.76 | 0.67 | 0.51 | 0.4 | 0.29 | 0.21 |
| EPS Diluted
| 1.59 | 1.15 | 0.61 | 0.58 | 0.66 | 0.85 | 0.52 | 0.41 | 0.45 | 0.7 | 0.75 | 0.76 | 0.67 | 0.51 | 0.4 | 0.29 | 0.21 |
| EBITDA
| 4,537.666 | 3,808.657 | 3,011.534 | 2,793.114 | 3,047.075 | 3,058.836 | 2,806.143 | 1,860.87 | 1,643.38 | 2,078.3 | 1,991.339 | 1,654.097 | 1,380.919 | 936.303 | 645.407 | 473.064 | 343.729 |
| EBITDA Ratio
| 0.215 | 0.201 | 0.174 | 0.17 | 0.173 | 0.187 | 0.245 | 0.217 | 0.212 | 0.259 | 0.292 | 0.281 | 0.268 | 0.233 | 0.199 | 0.18 | 0.169 |